Greater than 1 / 4 million new instances of the chikungunya virus have surfaced in South America this 12 months. New advances could quickly assist us outfox the virus, which may trigger debilitating joint ache.
AILSA CHANG, HOST:
The chikungunya virus is on the rise once more, together with in South America, the place greater than 1 / 4 million new instances have already surfaced this 12 months. The illness isn’t deadly, however it will probably go away long-lasting joint ache. As NPR’s Ari Daniel experiences, a vaccine could quickly be on the best way.
ARI DANIEL, BYLINE: Through the years, Dr. Susana Lloveras has seen instances of chikungunya in Buenos Aires, the place she works as an infectious illness doctor at Hospital Muniz.
SUSANA LLOVERAS: However it isn’t frequent for us – no multiple or two instances.
DANIEL: Every year, and at all times from folks bringing the mosquito-borne virus with them from different nations. However earlier this 12 months…
LLOVERAS: We obtain on a regular basis sufferers with chikungunya.
DANIEL: Together with some with no journey historical past, which suggests, for the primary time, mosquitoes inside Buenos Aires had been transmitting the illness. Case counts are up throughout Argentina. When somebody enters Lloveras’ hospital with chikungunya, there isn’t any mistaking it.
LLOVERAS: The sufferers got here right here with fever and with ache of their joints.
DANIEL: The joints of their palms and toes, says Lloveras, and their knees. The ache can get so dangerous that some have problem strolling and even holding a cup of espresso.
LLOVERAS: You might be nicely, and all of a sudden, you’ll be able to’t transfer. You want one other particular person enable you to do the frequent activity of on a regular basis.
DANIEL: Lloveras prescribes drugs to ease the fever and ache. However she tells her sufferers the illness simply has to run its course, which may be difficult as a result of some folks undergo from the joint ache for months or years although their immune programs have created antibodies to clear the virus.
MARGARET KIELIAN: We do not actually perceive what causes that debilitating arthritis.
DANIEL: Margaret Kielian is a virologist on the Albert Einstein School of Medication, and she or he and her colleagues discovered one thing that might carry us a step nearer to fixing this thriller. So most viruses make us sick by turning ourselves into virus-making machines. They launched a great deal of new viral particles that may go on to contaminate new cells. Chikungunya does that, nevertheless it additionally does one thing else.
KIELIAN: The virus induces the contaminated cell to generate these very dramatic lengthy extensions that may go from the contaminated cell to neighboring cells.
DANIEL: One or two tendrils, typically so long as the cell itself, snaking outwards – at instances towards uninfected cells. And although these tendrils could be bathed in antibodies…
KIELIAN: That contact between the contaminated cell and the uninfected cell shields the virus from the antibodies, and that is how that cell will get contaminated.
DANIEL: That’s, the virus can unfold by means of these extensions between cells, escaping assault by the immune system.
KIELIAN: It is early days, nevertheless it suggests this could be one mechanism by which the virus can form of get established – possibly in joint tissues. Which may be necessary in inflicting the arthritis. We’ll see.
DANIEL: This research, which was carried out in mice, was revealed within the journal Nature Microbiology.
NISCHAY MISHRA: This info may be very helpful.
DANIEL: Helpful to tell the event of vaccines for a illness whose footprint is rising, says Nischay Mishra. He is a virologist at Columbia College who wasn’t concerned within the research.
MISHRA: It is a world concern. Like, the best way local weather is altering, there are extra probabilities, like, mosquitoes can survive all over the place.
DANIEL: Chikungunya’s already an issue in locations like India, China and quite a few nations in Africa. Even within the U.S., Texas and Florida have, in earlier years, reported native transmission of the illness. Luckily, a number of vaccine efforts are underway, and Mishra says one could also be authorized as quickly as the tip of this 12 months.
Ari Daniel, NPR Information.
(SOUNDBITE OF NAV AND DON TOLIVER SONG, “ONE TIME”)
Copyright © 2023 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional info.
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content might not be in its ultimate kind and could also be up to date or revised sooner or later. Accuracy and availability could fluctuate. The authoritative document of NPR’s programming is the audio document.
